John Grous
Vice President, Medical Affairs (Consultant)
Biotechnology
Medelis
France
Biography
John Grous, M.D. is a board-certified medical oncologist with extensive experience in cancer therapeutic drug development. After eight years of an academic oncology practice in Boston serving as a Principal Investigator for Neupogen (Amgen) and other hematopoietic growth factors, Dr. Grous has served in the biotech and pharmaceutical industry from medical director to vice-president with several small companies. His last role was with AstraZeneca and part of the NDA team and accelerated FDA approval for the epidermal growth factor receptor antagonist, Iressa (gefitinb).
Research Interest
cancer therapeutic drug development
